{"id":862,"date":"2022-06-02T20:21:00","date_gmt":"2022-06-02T20:21:00","guid":{"rendered":"https:\/\/loucif.law\/?p=862"},"modified":"2022-06-03T20:23:45","modified_gmt":"2022-06-03T20:23:45","slug":"new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends","status":"publish","type":"post","link":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/","title":{"rendered":"New Policy in the Pharmaceutical Industry: First Assessment and Trends"},"content":{"rendered":"\n

Key points<\/p>\n\n\n\n

Since the adoption of an action plan by the Council of Ministers on 12 July
2020, an overhaul of the regulatory framework has been launched, resulting
in the publication by the Ministry of the Pharmaceutical Industry of more
than 40 regulatory texts, which have a deep impact on the activities of
importing, manufacturing, distributing and registering pharmaceutical
products.<\/p>\n\n\n\n

An initial assessment of this new policy can be summarised as follows:
\u2022 A saving of nearly 800 million euros on imports by 2021.
\u2022 Manufacturer status now available to establishments outsourcing their
production.
\u2022 An obligation to designate an “operator” when the marketing
authorisation is held by an entity in the country of origin.
\u2022 The promotion of exports through the granting of several advantages,
including the exemption from the 49\/51% rule.
\u2022 The introduction of several control mechanisms aimed at ensuring a
healthy and transparent functioning of the market, and detecting cases
of over-invoicing.<\/p>\n\n\n\n

For more information, the full version of this newsletter is available here<\/a><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Key points Since the adoption of an action plan by the Council of Ministers on 12 July2020, an overhaul of the regulatory framework has been launched, resultingin the publication by the Ministry of the Pharmaceutical Industry of morethan 40 regulatory texts, which have a deep impact on the activities ofimporting, manufacturing, distributing and registering pharmaceuticalproducts. […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-862","post","type-post","status-publish","format-standard","hentry","category-articles"],"acf":[],"yoast_head":"\nNew Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co\" \/>\n<meta property=\"og:description\" content=\"Key points Since the adoption of an action plan by the Council of Ministers on 12 July2020, an overhaul of the regulatory framework has been launched, resultingin the publication by the Ministry of the Pharmaceutical Industry of morethan 40 regulatory texts, which have a deep impact on the activities ofimporting, manufacturing, distributing and registering pharmaceuticalproducts. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/\" \/>\n<meta property=\"og:site_name\" content=\"Loucif & Co\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-02T20:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-03T20:23:45+00:00\" \/>\n<meta name=\"author\" content=\"bqorchi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bqorchi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/\"},\"author\":{\"name\":\"bqorchi\",\"@id\":\"https:\\\/\\\/loucif.law\\\/#\\\/schema\\\/person\\\/67b988086784ea5da1331e47e7284c86\"},\"headline\":\"New Policy in the Pharmaceutical Industry: First Assessment and Trends\",\"datePublished\":\"2022-06-02T20:21:00+00:00\",\"dateModified\":\"2022-06-03T20:23:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/\"},\"wordCount\":159,\"commentCount\":0,\"articleSection\":[\"Articles\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/\",\"url\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/\",\"name\":\"New Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/loucif.law\\\/#website\"},\"datePublished\":\"2022-06-02T20:21:00+00:00\",\"dateModified\":\"2022-06-03T20:23:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/loucif.law\\\/#\\\/schema\\\/person\\\/67b988086784ea5da1331e47e7284c86\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/loucif.law\\\/en\\\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/loucif.law\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Policy in the Pharmaceutical Industry: First Assessment and Trends\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/loucif.law\\\/#website\",\"url\":\"https:\\\/\\\/loucif.law\\\/\",\"name\":\"Loucif & Co\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/loucif.law\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/loucif.law\\\/#\\\/schema\\\/person\\\/67b988086784ea5da1331e47e7284c86\",\"name\":\"bqorchi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g\",\"caption\":\"bqorchi\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/","og_locale":"en_US","og_type":"article","og_title":"New Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co","og_description":"Key points Since the adoption of an action plan by the Council of Ministers on 12 July2020, an overhaul of the regulatory framework has been launched, resultingin the publication by the Ministry of the Pharmaceutical Industry of morethan 40 regulatory texts, which have a deep impact on the activities ofimporting, manufacturing, distributing and registering pharmaceuticalproducts. […]","og_url":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/","og_site_name":"Loucif & Co","article_published_time":"2022-06-02T20:21:00+00:00","article_modified_time":"2022-06-03T20:23:45+00:00","author":"bqorchi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"bqorchi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/#article","isPartOf":{"@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/"},"author":{"name":"bqorchi","@id":"https:\/\/loucif.law\/#\/schema\/person\/67b988086784ea5da1331e47e7284c86"},"headline":"New Policy in the Pharmaceutical Industry: First Assessment and Trends","datePublished":"2022-06-02T20:21:00+00:00","dateModified":"2022-06-03T20:23:45+00:00","mainEntityOfPage":{"@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/"},"wordCount":159,"commentCount":0,"articleSection":["Articles"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/","url":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/","name":"New Policy in the Pharmaceutical Industry: First Assessment and Trends - Loucif & Co","isPartOf":{"@id":"https:\/\/loucif.law\/#website"},"datePublished":"2022-06-02T20:21:00+00:00","dateModified":"2022-06-03T20:23:45+00:00","author":{"@id":"https:\/\/loucif.law\/#\/schema\/person\/67b988086784ea5da1331e47e7284c86"},"breadcrumb":{"@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/loucif.law\/en\/new-policy-in-the-pharmaceutical-industry-first-assessment-and-trends\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/loucif.law\/en\/"},{"@type":"ListItem","position":2,"name":"New Policy in the Pharmaceutical Industry: First Assessment and Trends"}]},{"@type":"WebSite","@id":"https:\/\/loucif.law\/#website","url":"https:\/\/loucif.law\/","name":"Loucif & Co","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/loucif.law\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/loucif.law\/#\/schema\/person\/67b988086784ea5da1331e47e7284c86","name":"bqorchi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/335d85880c719894ba30b16df0eae6b00988dd4be6ecbd92b4fb646b51026eb0?s=96&d=mm&r=g","caption":"bqorchi"}}]}},"_links":{"self":[{"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/posts\/862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/comments?post=862"}],"version-history":[{"count":3,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/posts\/862\/revisions"}],"predecessor-version":[{"id":865,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/posts\/862\/revisions\/865"}],"wp:attachment":[{"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/media?parent=862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/categories?post=862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/loucif.law\/en\/wp-json\/wp\/v2\/tags?post=862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}